A Team-Based Care for Hypertension Management (TBC-HTA)

Sponsor
Centre Hospitalier Universitaire Vaudois (Other)
Overall Status
Unknown status
CT.gov ID
NCT02511093
Collaborator
University of Applied Sciences of Western Switzerland (Other), Université du Québec à Trois-Rivières (Other), McGill University (Other)
110
1
2
51
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether a team-based care (TBC) intervention, combining physician, nurse and pharmacist care improves BP control compared to usual care at 6 months among outpatients with uncontrolled hypertension.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: TBC intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Team-Based Care for Hypertension Management (TBC-HTA): A Randomized Controlled Study
Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Jun 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: TBC intervention

A structured collaborative intervention delivered by trained nurses of ambulatory clinics and by community pharmacists working in collaboration with physicians during 6-month of follow-up includes: BP measurements; an educational and counselling intervention on patient adherence; an educational and counselling intervention on lifestyle (physical activity and diet). Physicians adjust antihypertensive medications based on nurse and pharmacist feedback.

Behavioral: TBC intervention
A structured collaborative intervention delivered by trained nurses of ambulatory clinics and by community pharmacists working in collaboration with physicians during 6-month of follow-up includes: BP measurements; an educational and counselling intervention on patient adherence; an educational and counselling intervention on lifestyle (physical activity and diet) Physicians adjust antihypertensive medications based on nurse and pharmacist feedback.

No Intervention: Usual care

Outcome Measures

Primary Outcome Measures

  1. Difference in daytime ABPM at 6-month between TBC and usual care patients [6-month]

    Difference in daytime ABPM at 6-month between TBC and usual care patients

  2. Difference in the proportion of patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 6-month between TBC and usual care patients [6-month]

    Difference in the proportion of patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 6-month between TBC and usual care patients

Secondary Outcome Measures

  1. Patients and healthcare professionals' acceptance and satisfaction with the TBC-intervention [6-month]

    Patients and healthcare professionals' acceptance and satisfaction with the TBC-intervention

  2. Difference in the proportion of TBC and usual care patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 12-month (6 months after intervention stopped) [12-month]

    Difference in the proportion of TBC and usual care patients with controlled blood pressure (daytime ABPM <135/85 mmHg) at 12-month (6 months after intervention stopped)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • treated patients with uncontrolled hypertension (defined as daytime systolic/diastolic ambulatory blood pressure monitoring (ABPM) ≥135/85mmHg) taking one or two antihypertensive medications;

  • speak and understand French;

  • agree to use the same pharmacy's services for the whole duration of the study.

Exclusion Criteria:
  • unable to understand the study aim;

  • pregnancy and lactating;

  • livimg in a nursing home;

  • hospitalization during the recruitment period;

  • participation in another study;

  • daytime ABPM>180/110 mmHg.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois Lausanne Vaud Switzerland 1011

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Vaudois
  • University of Applied Sciences of Western Switzerland
  • Université du Québec à Trois-Rivières
  • McGill University

Investigators

  • Principal Investigator: Valerie Santschi, PhD, Centre Hospitalier Universitaire Vaudois
  • Principal Investigator: Michel Burnier, MD, Centre Hospitalier Universitaire Vaudois

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Valérie Santschi, Dr. Valérie Santschi, PharmDipl, PhD, Centre Hospitalier Universitaire Vaudois
ClinicalTrials.gov Identifier:
NCT02511093
Other Study ID Numbers:
  • 449/13
First Posted:
Jul 29, 2015
Last Update Posted:
Jul 29, 2015
Last Verified:
Jul 1, 2015
Keywords provided by Valérie Santschi, Dr. Valérie Santschi, PharmDipl, PhD, Centre Hospitalier Universitaire Vaudois
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2015